{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:41:02Z","timestamp":1792737662915,"version":"4.5.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001711","name":"SNF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.immuni.2024.08.014","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T10:34:55Z","timestamp":1726223695000},"page":"2466-2482.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Tumor-reactive T\u00a0cell clonotype dynamics underlying clinical response to TIL therapy in melanoma"],"prefix":"10.1016","volume":"57","author":[{"given":"Johanna","family":"Chiffelle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Barras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9my","family":"P\u00e9tremand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Orcurto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bobisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Arnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aymeric","family":"Auger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca Navarro","family":"Rodrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Ghisoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Sauvage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Saugy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Murgues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mie","family":"Fahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Imbimbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ochoa de Olza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofiya","family":"Latifyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Genolet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Queiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisztian","family":"Homicsko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Michielin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Bassani-Sternberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana E.","family":"Kandalaft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urania","family":"Dafni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Corria-Osorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Trueb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denarda","family":"Dangaj Laniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Harari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Coukos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2024.08.014_bib1","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1093\/annonc\/mdz398","article-title":"Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis","volume":"30","author":"Dafni","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.immuni.2024.08.014_bib2","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1158\/1078-0432.CCR-11-0116","article-title":"Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy.","volume":"17","author":"Rosenberg","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.immuni.2024.08.014_bib3","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa2210233","article-title":"Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma","volume":"387","author":"Rohaan","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2024.08.014_bib4","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/s41591-021-01462-y","article-title":"Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial","volume":"27","author":"Creelan","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2024.08.014_bib5","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1609279","article-title":"T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer","volume":"375","author":"Tran","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2024.08.014_bib6","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41591-018-0040-8","article-title":"Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer","volume":"24","author":"Zacharakis","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2024.08.014_bib7","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1158\/1078-0432.CCR-18-2722","article-title":"A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus\u2013associated Epithelial Cancers","volume":"25","author":"Stevanovi\u0107","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.immuni.2024.08.014_bib8","article-title":"Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead","volume":"9","author":"Kirtane","year":"2021","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.immuni.2024.08.014_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41591-018-0266-5","article-title":"Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers","volume":"25","author":"Scheper","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2024.08.014_bib10","doi-asserted-by":"crossref","first-page":"7726","DOI":"10.4049\/jimmunol.176.12.7726","article-title":"Modulation by IL-2 of CD70 and CD27 expression on CD8+ T\u00a0cells: importance for the therapeutic effectiveness of cell transfer immunotherapy","volume":"176","author":"Huang","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2024.08.014_bib11","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1158\/1078-0432.CCR-12-1177","article-title":"Specific Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-Infiltrating Lymphocytes in Metastatic Melanoma Patients","volume":"18","author":"Radvanyi","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.immuni.2024.08.014_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00002371-200501000-00007","article-title":"Persistence of Multiple Tumor-Specific T-Cell Clones Is Associated with Complete Tumor Regression in a Melanoma Patient Receiving Adoptive Cell Transfer Therapy","volume":"28","author":"Zhou","year":"2005","journal-title":"J.\u00a0Immunother."},{"key":"10.1016\/j.immuni.2024.08.014_bib13","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1158\/2326-6066.CIR-19-0299","article-title":"Single-cell transcriptome analysis reveals gene signatures associated with T-cell persistence following adoptive cell therapy","volume":"7","author":"Lu","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.immuni.2024.08.014_bib14","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150535","article-title":"Neoantigen-reactive CD8+ T\u00a0cells affect clinical outcome of adoptive transfer with tumor-infiltrating lymphocytes in melanoma","volume":"132","author":"Kristensen","year":"2022","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.immuni.2024.08.014_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01460-0","article-title":"Mutational and putative neoantigen load predict clinical benefit of adoptive T\u00a0cell therapy in melanoma","volume":"8","author":"Lauss","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2024.08.014_bib16","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1126\/science.abl5447","article-title":"Molecular signatures of antitumor neoantigen-reactive T\u00a0cells from metastatic human cancers","volume":"375","author":"Lowery","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.immuni.2024.08.014_bib17","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41422-022-00627-9","article-title":"Defined tumor antigen-specific T\u00a0cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response","volume":"32","author":"He","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.immuni.2024.08.014_bib18","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ccell.2022.03.005","article-title":"Transcriptomic profiles of neoantigen-reactive T\u00a0cells in human gastrointestinal cancers","volume":"40","author":"Zheng","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2024.08.014_bib19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ccell.2022.03.012","article-title":"A phenotypic signature that identifies neoantigen-reactive T\u00a0cells in fresh human lung cancers","volume":"40","author":"Hanada","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2024.08.014_bib20","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ccell.2022.03.006","article-title":"Neoantigen-specific CD4+ T\u00a0cells in human melanoma have diverse differentiation states and correlate with CD8+ T\u00a0cell, macrophage, and B cell function","volume":"40","author":"Veatch","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2024.08.014_bib21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41586-021-03704-y","article-title":"Phenotype, specificity and avidity of antitumour CD8+ T\u00a0cells in melanoma","volume":"596","author":"Oliveira","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2024.08.014_bib22","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2018.11.043","article-title":"Dysfunctional CD8\u00a0T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma","volume":"176","author":"Li","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2024.08.014_bib23","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1158\/1078-0432.CCR-19-3845","article-title":"The Outcome of Ex Vivo TIL Expansion Is Highly Influenced by Spatial Heterogeneity of the Tumor T-Cell Repertoire and Differences in Intrinsic In Vitro Growth Capacity between T-Cell Clones","volume":"26","author":"Poschke","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.immuni.2024.08.014_bib24","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.abb9847","article-title":"Stem-like CD8 T\u00a0cells mediate response of adoptive cell immunotherapy against human cancer","volume":"370","author":"Krishna","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.immuni.2024.08.014_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adg7995","article-title":"Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8+ T-myeloid cell networks in melanoma","volume":"9","author":"Barras","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2024.08.014_bib26","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1084\/jem.20081382","article-title":"Self-antigen\u2013specific CD8+ T\u00a0cell precursor frequency determines the quality of the antitumor immune response","volume":"206","author":"Rizzuto","year":"2009","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2024.08.014_bib27","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/blood.2020006770","article-title":"Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies","volume":"137","author":"Gauthier","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2024.08.014_bib28","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1172\/JCI85309","article-title":"CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients","volume":"126","author":"Turtle","year":"2016","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.immuni.2024.08.014_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.02186","article-title":"Pro-tumor \u03b3\u03b4 T Cells in Human Cancer: Polarization, Mechanisms of Action, and Implications for Therapy","volume":"11","author":"Chabab","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.immuni.2024.08.014_bib30","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1182\/blood-2011-10-386482","article-title":"Levels of peripheral CD4(+)FoxP3(+) regulatory T\u00a0cells are negatively associated with clinical response to adoptive immunotherapy of human cancer","volume":"119","author":"Yao","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2024.08.014_bib31","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s00262-018-2237-6","article-title":"TCR repertoire profiling of tumors, adjacent normal tissues, and peripheral blood predicts survival in nasopharyngeal carcinoma","volume":"67","author":"Jin","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.immuni.2024.08.014_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-14273-0","article-title":"Comprehensive T\u00a0cell repertoire characterization of non-small cell lung cancer","volume":"11","author":"Reuben","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2024.08.014_bib33","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41586-020-2056-8","article-title":"Peripheral T\u00a0cell expansion predicts tumour infiltration and clinical response","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2024.08.014_bib34","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s41591-019-0522-3","article-title":"Clonal replacement of tumor-specific T\u00a0cells following PD-1 blockade","volume":"25","author":"Yost","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2024.08.014_bib35","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.copbio.2020.07.010","article-title":"T-cell repertoire analysis and metrics of diversity and clonality","volume":"65","author":"Chiffelle","year":"2020","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.immuni.2024.08.014_bib36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1158\/1078-0432.CCR-13-0945","article-title":"CD137 accurately identifies and enriches for naturally occurring tumor-reactive T\u00a0cells in tumor","volume":"20","author":"Ye","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.immuni.2024.08.014_bib37","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/s41587-021-01072-6","article-title":"Sensitive identification of neoantigens and cognate TCRs in human solid tumors","volume":"40","author":"Arnaud","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.immuni.2024.08.014_bib38","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","article-title":"T Cell Dysfunction in Cancer","volume":"33","author":"Thommen","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2024.08.014_bib39","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41591-018-0045-3","article-title":"Global characterization of T\u00a0cells in non-small-cell lung cancer by single-cell sequencing","volume":"24","author":"Guo","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2024.08.014_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe6474","article-title":"Pan-cancer single-cell landscape of tumor-infiltrating T\u00a0cells","volume":"374","author":"Zheng","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.immuni.2024.08.014_bib41","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41568-019-0235-4","article-title":"CD8\u00a0+ T\u00a0cell states in human cancer: insights from single-cell analysis","volume":"20","author":"van der Leun","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.immuni.2024.08.014_bib42","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.ccell.2021.10.008","article-title":"Myeloid antigen-presenting cell niches sustain antitumor T\u00a0cells and license PD-1 blockade via CD28 costimulation","volume":"39","author":"Duraiswamy","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2024.08.014_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03301-0","article-title":"Sensitive and frequent identification of high avidity neo-epitope specific CD8\u00a0+ T\u00a0cells in immunotherapy-naive ovarian cancer","volume":"9","author":"Bobisse","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2024.08.014_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-38946-z","article-title":"Neoantigen-specific CD8 T\u00a0cells with high structural avidity preferentially reside in and eliminate tumors","volume":"14","author":"Schmidt","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2024.08.014_bib45","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.humimm.2004.01.005","article-title":"Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men","volume":"65","author":"Holling","year":"2004","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.immuni.2024.08.014_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12464-3","article-title":"Single-cell transcriptomics of human T\u00a0cells reveals tissue and activation signatures in health and disease","volume":"10","author":"Szabo","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2024.08.014_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01904","article-title":"The Emerging Role of CD8+ Tissue Resident Memory T (TRM) Cells in Antitumor Immunity: A Unique Functional Contribution of the CD103 Integrin","volume":"9","author":"Corgnac","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.immuni.2024.08.014_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05072-0","article-title":"Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T\u00a0cells in human solid tumors","volume":"9","author":"Duhen","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2024.08.014_bib49","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1476-4598-13-178","article-title":"HMGN2, a new anti-tumor effector molecule of CD8+ T\u00a0cells","volume":"13","author":"Su","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.immuni.2024.08.014_bib50","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.immuni.2020.11.005","article-title":"Comprehensive Profiling of an Aging Immune System Reveals Clonal GZMK+ CD8+ T Cells as Conserved Hallmark of Inflammaging","volume":"54","author":"Mogilenko","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2024.08.014_bib51","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00262-009-0804-6","article-title":"Regulation of immunity and oncogenesis by the IRF transcription factor family","volume":"59","author":"Savitsky","year":"2010","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.immuni.2024.08.014_bib52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.metabol.2017.08.011","article-title":"Immunometabolic profiling of T\u00a0cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration","volume":"77","author":"La Rocca","year":"2017","journal-title":"Metabolism"},{"key":"10.1016\/j.immuni.2024.08.014_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aap9520","article-title":"Impaired enolase 1 glycolytic activity restrains effector functions of tumor-infiltrating CD8+ T\u00a0cells","volume":"4","author":"Gemta","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2024.08.014_bib54","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41586-019-0979-8","article-title":"Genome-wide analysis identifies NR4A1 as a key mediator of T\u00a0cell dysfunction","volume":"567","author":"Liu","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2024.08.014_bib55","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4049\/jimmunol.175.2.647","article-title":"E2F1 and E2F2 are differentially required for homeostasis-driven and antigen-induced T\u00a0cell proliferation in\u00a0vivo","volume":"175","author":"DeRyckere","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2024.08.014_bib56","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.immuni.2020.09.005","article-title":"Central memory CD8+ T\u00a0cells derive from stem-like Tcf7hi effector cells in the absence of cytotoxic differentiation","volume":"53","author":"Pais Ferreira","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2024.08.014_bib57","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.immuni.2019.09.013","article-title":"TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T\u00a0cell-Fate Decision","volume":"51","author":"Chen","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2024.08.014_bib58","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2021.02.019","article-title":"In\u00a0vivo CD8+ T\u00a0cell CRISPR screening reveals control by Fli1 in infection and cancer","volume":"184","author":"Chen","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2024.08.014_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23044-9","article-title":"Antigen-driven EGR2 expression is required for exhausted CD8+ T\u00a0cell stability and maintenance","volume":"12","author":"Wagle","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2024.08.014_bib60","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1158\/2159-8290.CD-22-1175","article-title":"Type I Interferon Signaling via the EGR2 Transcriptional Regulator Potentiates CAR T Cell\u2013Intrinsic Dysfunction","volume":"13","author":"Jung","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.immuni.2024.08.014_bib61","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/s41590-021-00979-1","article-title":"Epigenetic scars of CD8+ T\u00a0cell exhaustion persist after cure of chronic infection in humans","volume":"22","author":"Yates","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2024.08.014_bib62","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s41590-021-00975-5","article-title":"Epigenetic scarring of exhausted T\u00a0cells hinders memory differentiation upon eliminating chronic antigenic stimulation","volume":"22","author":"Abdel-Hakeem","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2024.08.014_bib63","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/intimm\/dxy050","article-title":"Crucial role of CD69 in anti-tumor immunity through regulating the exhaustion of tumor-infiltrating T\u00a0cells","volume":"30","author":"Mita","year":"2018","journal-title":"Int. Immunol."},{"key":"10.1016\/j.immuni.2024.08.014_bib64","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4161\/onci.18851","article-title":"TIL therapy broadens the tumor-reactive CD8+ T\u00a0cell compartment in melanoma patients","volume":"1","author":"Kvistborg","year":"2012","journal-title":"OncoImmunology"},{"key":"10.1016\/j.immuni.2024.08.014_bib65","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2024.08.014_bib66","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1182\/blood-2011-04-348540","article-title":"Safety and persistence of adoptively transferred autologous CD19-targeted T\u00a0cells in patients with relapsed or chemotherapy refractory B-cell leukemias","volume":"118","author":"Brentjens","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2024.08.014_bib67","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/nm.2446","article-title":"A human memory T\u00a0cell subset with stem cell\u2013like properties","volume":"17","author":"Gattinoni","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2024.08.014_bib68","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/s41591-018-0057-z","article-title":"A transcriptionally and functionally distinct PD-1+ CD8+ T\u00a0cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade","volume":"24","author":"Thommen","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2024.08.014_bib69","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy.","volume":"50","author":"Siddiqui","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2024.08.014_bib70","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8+ T\u00a0cells differentially mediate tumor control and respond to checkpoint blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2024.08.014_bib71","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1200\/JCO.21.00612","article-title":"Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma","volume":"39","author":"Sarnaik","year":"2021","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.immuni.2024.08.014_bib72","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1016\/j.immuni.2023.11.005","article-title":"Stat5 opposes the transcription factor Tox and rewires exhausted CD8+ T\u00a0cells toward durable effector-like states during chronic antigen exposure","volume":"56","author":"Beltra","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2024.08.014_bib73","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ccell.2019.05.004","article-title":"Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors","volume":"35","author":"Dangaj","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2024.08.014_bib74","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.immuni.2020.04.014","article-title":"Developmental Relationships of Four Exhausted CD8+ T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms","volume":"52","author":"Beltra","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2024.08.014_bib75","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41591-018-0010-1","article-title":"Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T\u00a0cell therapy of chronic lymphocytic leukemia","volume":"24","author":"Fraietta","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2024.08.014_bib76","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1126\/science.abq0225","article-title":"Decoding CAR T\u00a0cell phenotype using combinatorial signaling motif libraries and machine learning","volume":"378","author":"Daniels","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.immuni.2024.08.014_bib77","article-title":"Understanding T\u00a0cell phenotype for the design of effective chimeric antigen receptor T\u00a0cell therapies","volume":"9","author":"Tantalo","year":"2021","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.immuni.2024.08.014_bib78","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba7365","article-title":"CRISPR-engineered T\u00a0cells in patients with refractory cancer","volume":"367","author":"Stadtmauer","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.immuni.2024.08.014_bib79","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41590-023-01477-2","article-title":"Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8+ T\u00a0cells","volume":"24","author":"Corria-Osorio","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2024.08.014_bib80","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1038\/s41591-023-02415-3","article-title":"Transcriptional signatures associated with persisting CD19 CAR-T cells in children with leukemia","volume":"29","author":"Anderson","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2024.08.014_bib81","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1038\/s41591-022-01916-x","article-title":"Tumor immune contexture is a determinant of anti-CD19 CAR T\u00a0cell efficacy in large B cell lymphoma","volume":"28","author":"Scholler","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2024.08.014_bib88","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2008-9-9-r137","article-title":"Model-based analysis of ChIP-Seq (MACS)","volume":"9","author":"Zhang","year":"2008","journal-title":"Genome Biol."},{"key":"10.1016\/j.immuni.2024.08.014_bib82","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jcyt.2020.07.011","article-title":"Development of an optimized closed and semi-automatic protocol for Good Manufacturing Practice manufacturing of tumor-infiltrating lymphocytes in a hospital environment","volume":"22","author":"Gannon","year":"2020","journal-title":"Cytotherapy"},{"key":"10.1016\/j.immuni.2024.08.014_bib83","article-title":"TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs","volume":"3","author":"Genolet","year":"2023","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.immuni.2024.08.014_bib84","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","article-title":"Lineage tracking reveals dynamic relationships of T\u00a0cells in colorectal cancer","volume":"564","author":"Zhang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2024.08.014_bib85","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.immuni.2019.03.009","article-title":"Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species","volume":"50","author":"Zilionis","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2024.08.014_bib86","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","article-title":"A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade","volume":"175","author":"Jerby-Arnon","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2024.08.014_bib87","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23324-4","article-title":"Interpretation of T\u00a0cell states from single-cell transcriptomics data using reference atlases","volume":"12","author":"Andreatta","year":"2021","journal-title":"Nat. Commun."}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761324004138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761324004138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T23:24:45Z","timestamp":1759965885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761324004138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":88,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1074761324004138"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2024.08.014","relation":{},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-reactive T\u00a0cell clonotype dynamics underlying clinical response to TIL therapy in melanoma","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2024.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}